As a result of an increasing number of drugs turning off-patent and greater acceptance of generic drugs in regulated markets, pharmaceutical exports from India will reach 500 billion rupees ($11.06 billion) in the current fiscal, according to the Pharmaceutical Exports Promotion Council’s (Pharmexcil) executive director, PV Appaji.
He said that that Indian pharmaceutical exports in the last fiscal year amounted to 420 billion rupees, and he expect this to grow by 20% this year, as the sector is coming of the recession effect, reports the local newspaper the Financial Chronicle.
During 2009-10, pharmaceutical exports saw only 4.13% growth over the previous year. While the effect of slowdown on the other sectors was visible during 2008-09, pharmaceuticals witnessed it only during 2009-10. “The inventories of drugs lasted for the 2009-10 period when the slowdown was at its peak,” Mr Appaji said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze